PBI's 2008 Revenues Rise 32 Percent; Firm Set to Launch 'Important' Product in Q2
April 02, 2009
PBI's 2008 Revenues Rise 32 Percent; Firm Set to Launch 'Important' Product in Q2
In addition, the company's CEO said this week the firm is on track to lower its quarterly cash-burn rate to below $600,000 for 2009. The reduction has been enabled by a restructuring undertaken in December and improved sales.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Theranostics Health Launching Alternative to Formalin for Preserving Phosphoproteomic Tissue Samples
September 2, 2011 / ProteoMonitor - Pressure BioSciences Aims to Raise $5M to Regain Compliance with Nasdaq Listing Requirements
June 17, 2011 / ProteoMonitor - PBI Reports 49-Percent Rise in Q2 Revenues, Plans to Focus on Mass-Spec Sample Prep
August 20, 2010 / ProteoMonitor - Pressure BioSciences Signs R&D Agreement with the AFIP, ARM, VA for FFPE Protein Extraction
May 28, 2010 / ProteoMonitor - Pressure Bio's FY 2008 Revenues Rise 32 Percent
March 31, 2009 / GenomeWeb Daily News